chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Saturday morning , 1/30/2021 my left eye became red, and was very painful by Sunday, 1/31/2021. My eye had a red spot with yellowish veins to the left of my pupil, and it felt inflamed and swollen. Made an appt. with Dr., my eye doctor, for Monday 2/1/2021 and was diagnosed with  Episcleritis and prescribed steroid eye drops.  Dr. explained the cause of  Episcleritis is somewhat unknown, but it's an inflammatory reaction that's not uncommon for people with other auto-immune concerns. He was unsure if the  Episcleritis was caused by the COVID-19 Vaccine, but advised me to report it to the specific app, so I did. I did NOT have another reaction after the second shot.
1/9/12 - Fever 102.3 went to ER - Dx. 1/20/12 - Office visit - ptosis of right eyelid. 1/21/12 - Medical center - dx fever of unknown origin.
Mmuscle weakness in upper arm where shot was injected -- weakness is still present 6 weeks later.
Patient at the time of sending him to wait 15 minutes after administering the vaccine was fine. At 5 minutes he began to cough constantly, with nausea, dizziness and feeling really hot in his body. I told him to enter the vaccination room and that we should call 911, which he refused, the patient could breathe and did not lose consciousness at any time. Depo medrol and benadryl 50mg / ml were administered at 11:14 am. blood pressure was taken at 11:20 am 128/87 pulse: 73. Patient began to calm down and feel better little by little. He was given alcohol to smell. At 11:25 am the pressure was taken back to 127/76 and set to 61. He was already starting to feel better. He was told to remain under observation for 20 more minutes, he was with his partner in the chairs waiting for vaccination. At 11:37 am his pressure was taken again 121/79 pulse in 58. He decided to go to bed at home. He was advised to contact his doctor to validate if the second dose should be administered and to go to the emergency room to continue with symptoms. At 2:00 pm, I contacted the patient who had a fever and headache and contacted his pulmonologist to tell him what happened, he told him that he would evaluate if he should take the second dose.
Along with expected side effects like fever and chills, I developed an oval rash over the injection site by the following evening. It was swollen and warm to the touch but not painful or itchy. By day 3 after the vaccine, it has moved location (below the injection site) and spread around the arm over the bicep and tricep. It is also now very itchy and still warm, slightly sore when I touch it but otherwise not painful. I have tried taking an antihistamine but it still feels prickly/itchy.
A second booster of Pfizer Covid 19 was given to a 33 year old healthy male.  Upon realizing the mistake the client was called on 7/19/2022 to inform him that he received a dose that is currently not approved to be given to a person under 50 years of age.  Client states he is not experiencing any complications that he did not experience with his other vaccines.  The fever and arm soreness was gone with 24 hours, his lymph node is still sore but he states it is geting better.
Developed abdominal pain/nausea/gas/diarrhea in June, was eventually diagnosed with IBS at the end of June. I am working on managing it now but it can't be cured.
Three weeks after the first vaccination I had hives for two days.  Two weeks after the second vaccination I had hives for 3 days.  No anaflaxis occurred.  Also,   five days after the first vaccination I had a CT scan that alerted my cancer doctor to a possible breast issue.  After having a mammogram and ultra sound the Doctor felt I may have a swollen gland as a result of the shot.  I am to have a follow up ultra sound three months from the latest vaccination.
This spontaneous report as received from a physician via company representative refers to a 64 years old female patient. The patient's medical history included bell palsy. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and lot number were not reported) for shingles vaccination. Concomitant medications were not reported. On an unknown date, 2-3 weeks after received ZOSTAVAX the patient developed bell's palsy. Patient received unspecified prescription drug as treatment for the bell's palsy. The outcome of bell's palsy was reported as not recovered/not resolved. The relationship between ZOSTAVAX and the events was not reported. Patient spoke with the physician. This case is linked to case 1308USA009652 via same reporter link. Additional information has been requested.
Patient had a rash around the site of administration (itchy, warm to the touch). Rash started on 09/17. Patient was advised to take OTC Benadryl and follow up with her doctor.
Patient came in for his first shot of Moderna. Per the nurse, upon administering the vaccine, the needle and syringe came apart. Pharmacist notified and aware of the situation, she approved the nurse to give another dose.  Patient aware of the situation and comfortable with receiving another dose.
Information has been received from a registered nurse concerning a 20 year old female patient with no pertinent medical history and no known drug allergies or reactions who in October 2008 was vaccinated with the first dose of GARDASIL.  The patient had no problems with dose 1.  On an unspecified date the patient was vaccinated with the second dose of GARDASIL vaccine at a different facility.  Concomitant therapy included hormonal contraceptives (unspecified).  Subsequently the patient experienced scarring at the injection site.  There was a white ring at the injection site that was 2 and 1/2 centimeters in diameter and it looked like a "puncture scar".  There was no pain and no swelling.  No lab diagnostics studies were performed.  At the time of reporting, the patient's scarring at the injection site persisted.  The patient sought medical attention via office visit.  Additional information has been requested
sore shoulder; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A 59-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6204), dose 1 via an unspecified route of administration, administered in left arm on 10Mar2021 at 09:30 (at the age of 59-years-old) as DOSE 1, SINGLE for covid-19 immunisation (to not catch Covid. He works with the public. To not infect anyone else). Medical history included ongoing hypertension from an unspecified date (high blood pressure) reported as He takes medication for high blood pressure. Concomitant medication included unspecified medication for high blood pressure. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. No prior vaccinations within 4 weeks. Patient Medical History (including any illness at time of vaccination) was none. Family Medical History Relevant to AEs was none. On 11Mar2021, the next day after vaccination patient experienced sore shoulder. While reporting on friend, the patient added that he received both doses of the Pfizer vaccine. He did not have any problems except for a sore shoulder. It lasted for about 12 hours. He gets weekly texts to see if he has a reaction. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 31Mar2021 (at the age of 59-years-old) (Batch/Lot Number: EP6955) as DOSE 2, SINGLE for covid-19 immunisation. Event did not require a visit to Emergency Room or Physician Office. Relevant Tests done were none. Reporter seriousness for sore shoulder was Unspecified. The outcome of sore shoulder was resolved on 12Mar2021.  No follow-up attempts are needed. No further information is expected.
hearing loss, dizziness, nausea & vomiting, vertigo, fell, lost balance;
Pt received PCV 13 on R deltoid on 2/17/16, and started 2/17/16 9 pm, had fever, dizziness and nausea, temp went as high as 105F (41 degree Celsius), and had to keep taking Tylenol to keep fever down, temp tends to spike higher at night. Here to seek urgent care. R deltoid area of arm is mild reddened and swelling, tender to touch. Pt also c/o right arm and right leg spasm since PCV 13 was injected. Currently rating R arm pain at 8/10. Afebile now at 98.7 F.
After the first injection, approximately 24 hours later I got my period. With the period I had extreme pain, and my flow was extremely heavy. I had never had so much blood and fluid before in my life. The size of the tissue that I was menstruating was very very large and the pain and heavy menstruating went on until the end of the week (it never decreased or became better). Then after the second dose the same thing happened - not even 24 hours later I got my period with extreme pain, very large chunks of tissue, and extreme flow of blood. Then my third period the same exact thing has happened, extreme pain, very very large chunks of tissue, and extremely heavy flow.
2 days after receiving my first shot I started to feel nauseous and that was pretty slight on day 3 and got really uncomfortable on day 4. On day 4 I was nauseous  all day up to day 9.  On day 5 I started feeling chest pain right below my ribs in the center of my chest. If I sat up it was very uncomfortable and if I layed down the pain seemed to lessen.  On day 4 it seemed to throw my stomach off and up to day 9 I seemed to me more constipated. On day 5-8 I felt extremely  lethargic and need to nap which is something that I never do
I have experienced Chronic Spontaneous Urticaria all over my body for the last 8 days. It is itchy, burning, and randomly appears and disappears in different areas. Mostly under arms(pits and rib area), groin, neck and head, and back. Not a lot has appeared on my lower legs, but my feet have itched really bad a few times during the last eight days. It is exactly like most of the descriptions on this page I have been taking Allegra in the morning and Benadryl at night.
Dizziness and vertigo that has persisted since 4-21-2021. Today is 5-4-2021.
By evening, became so cold and started shaking so hard for several hrs. Went to bed w/ heavy blanket and socks. Later became very hot. Ached all over. Was in bed 2 days miserable with red rash on torso, legs and arms that lasted itching for 3 days. Took BENADRYL.
shooting pain that goes from deltoid to my elbow around the injection site; couldn't lift up my arm, pain comes and goes / some tenderness; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (Age: 76, Unit: Unknown as reported) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration on 04Feb2021 as 2nd dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced shooting pain that goes from deltoid to my elbow around the injection site and couldn't lift up my arm, pain comes and goes / some tenderness. It was reported that the patient was asking if there was a list of reported side effects that last for weeks and months. The patient had her second dose of the Pfizer COVID vaccine on 04Feb2021. Ever since she has been experiencing intermittent shooting pain that goes from deltoid to my elbow around the injection site. One night she was laying down with a book in her hand, she couldn't lift up her arm. The pain comes and goes and there was some tenderness. The patient wanted to know if it's normal for the side effects to last that long. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Felt a cold feeling immediately in the area of the shot. In the evening of the first day of the shot, began to feel very sore in the left arm & shoulder. Went to bed at midnight. Woke up every hour with very sore shoulder. By 5:00 am, could not bare the pain in the arm & shoulder. Extremely uncomfortable. Very difficult to lift left arm to do anything. Pain also up to neck area with a headache. Have fought headaches for 60 years. Had examine & advised that I have with the authorities and curvature of the spine. May have been cause by an accident when I was 20 years old.
Received vaccine on 9/5/08.  On 10/29 I woke up numb on right side of abdomen.  Thinking it was a pinched nerve I allowed it to go on for several days while the numbness extended from right chest to mid-thigh.  I went to the E.R. on sat 11/1 where an MRI was done showing demyelination on my cervical spine. A Neurologist diagnosed me w/transverse myelitis.  I remained in the hospital for 2 days with IV steroids then returned home on IV steroids.  I have since had a 2nd hospitalization w/another MRI showing a 2nd lesion on the thoracic spine.  All blood work & Lumbar Puncture came back normal.  Since the 2nd hospitalization I have been diagnosed with Multiple Sclerosis.  9/8/09 Hospital records received DOS inpatient 11/1/08 to 11/3/08, outpatient visits, inpatient 7/18/09 to 7/20/09. Assessment: Transverse myelitis. Steroid induced glucose intolerance. Adjustment reaction. Patient presented with numbness starting at the right lower thorax and upper abdomen, spreading to thigh, knee, and to neck. Difficulty with balance. Pressure headache right side. Symptoms of heaviness (R) face. Arthritic changes fingers. Malaise and fatigue. Hyperglycemia. Perioral dermatitis. 9/18/09 neuro consult received dated 1/12/08 toxx. Initially Dx'd with Transverse Myelitis, later dx of Multiple sclerosis  based on 2 episodes of demyelinating plaques on 2 seperate occasions.
Red circle at the injection site that has grown larger everyday; Swollen; hot to the touch.; Hurts and itches at the same time; Hurts and itches at the same time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07Mar2022 16:00 (Lot number: FK9895) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: FC8132, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 30Aug2021, when the patient was 48 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: FC3180, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 02Aug2021, when the patient was 48 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE RASH (non-serious) with onset 08Mar2022, outcome "unknown", described as "Red circle at the injection site that has grown larger everyday"; SWELLING (non-serious) with onset 08Mar2022, outcome "unknown", described as "Swollen"; FEELING HOT (non-serious) with onset 08Mar2022, outcome "unknown", described as "hot to the touch."; PAIN (non-serious), PRURITUS (non-serious) all with onset 08Mar2022, outcome "unknown" and all described as "Hurts and itches at the same time". The events "red circle at the injection site that has grown larger everyday", "swollen", "hot to the touch.", "hurts and itches at the same time" and "hurts and itches at the same time" were evaluated at the physician office visit. Therapeutic measures were taken as a result of vaccination site rash, swelling, feeling hot, pain, pruritus. Additional Information: Prior vaccinations within 4 weeks were reported as none. COVID tested prior vaccination and tested post vaccination were reported as none. Treatment received for the events were reported as antibiotics. The patient reported that red circle at the injection site that has grown larger every day. Swollen, hot to the touch. Hurts and itches at the same time. The outside ring of the circle has gotten darker and redder and wider as more time goes by.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a register nurse concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 08-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (dose number and route were not reported), 0.5 ml, lot # K005182, expiration date 10-APR-2014 for vaccination. Co-suspect and concomitant therapies were not reported. The register nurse reported patient experienced 26 patients received doses of (Oka/Merck) VARIVAX (from lot # K005182, expiration date 10-APR-201 only) that were improperly stored. No adverse effect reported for any of the patients. This is one (1) of twenty seven (27) reports from the same reporter.
vaccination provided around 12:15 p.m. on 10/12. No immediate reaction.  Around 2:30 I began to feel ill, nauseous, with strong pain in my stomach area below the breastbone. It lasted for about 3 hours and began to subside, although I still was feeling ill.  I slept fitfully during the night. Feel fairly well today, and no pain.
patient received flu shot. after shot, I had disarmed the needle with safety clip and syringe was lowered into sharps container. when lowering, needle had poked through nitrile glove piercing left index finger.  the safety clip had not fully disarmed the needle and therefore poked through the glove
Fever which started approx 9 days after MMR vaccine. Chills, body aches, rash on face, limbs, trunk beginning 14 days after vaccine. No childhood vaccinations.
still got shingles on my scalp/ Suspected vaccination failure; still got shingles on my scalp; so stress has compromised my immune system; so stress has compromised my immune system; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 70-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, stress and immune system disorder. On an unknown date, the outcome of the vaccination failure, shingles, stress and immune system disorder were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, stress and immune system disorder to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 13-AUG-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The patient had received both doses of Shingles vaccine and still had got shingles on her scalp. She had a disabled husband, so stress had compromised her immune system. The first dermatologist she saw told her that she had folliculitis, so she was put on wrong prescription (Rx). She had got second opinion after the symptoms were getting worsen. The patient stated that did not wait.  Additional supportive information: This case was considered as suspected vaccination failure since details regarding time to onset and laboratory confirmation of shingles was reported at the time of reporting. Follow-up would not possible as no contact details were available.
I experienced dizziness, a severe headache pain radiating from the right arm, Weakness and numbness on the right side of my body, fatigue and shortness of breath.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 1:54 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 1:32 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 66.76 for dose administered on 02-Mar-2021 and 66.84 for dose administered on 30-Mar-2021 .  No concomitant medications were reported.  Batch number 014M20A underwent temperature excursion on 02-Mar-2021 with temperature 33 degrees Fahrenheit from 12:00 PM . This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 02-Mar-2021 .  Batch number 019B21A underwent temperature excursion on 30-Mar-2021 with temperature 33 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-April-2021. Product moved to clinic on  30-Mar-2021 .   Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
received an expired dose / (expiration date: June 5th,2021) on June 8th, 2021; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 97NL3, expiry date 5th June 2021) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th June 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 8th June 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: On 8th June 2021, the patient received Boostrix which was expired on 5th June 2021. Patient initial was not provided. The reporter consented to follow up.
Large local and systemic reaction to imm. after urticarial lesion of right arm; itchy eyes and mouth.